$VSTR announced the successful completion of a pri
Post# of 37074
(Total Views: 121)
Posted On: 04/10/2019 8:38:46 AM
$VSTR announced the successful completion of a private capital raise for Phoenix PharmaLabs, one of the company’s digital marketing clients. ValueSetters assisted with the Reg CF portion of the raise, which was oversubscribed on the Netcapital platform.
“The ValueSetters team was proud and honored to work with Phoenix PharmaLabs, a company that is working to address the opioid crisis with their non-addictive pain killer,” said Cecilia Lenk, CEO of ValueSetters. “Phoenix PharmaLabs has a powerful mission. More than 2 million Americans are seriously addicted to opioids, and the funds that were raised in their offering will be used to help address this national crisis.”
“ValueSetters played a critical role in the success of our offering,” said Bill Crossman, President & CEO of Phoenix PharmaLabs. “Their unique expertise in the digital marketing of private capital raises drove significant investment dollars. They really rose to the challenge, and we were pleased with their collaborative approach.”
Jackson Stone, Head of Business Development at Netcapital, added, “We referred Phoenix PharmaLabs to ValueSetters because Phoenix sought support from an experienced partner in our industry, and we are happy they chose to work together. The impressive results Phoenix and ValueSetters generated speak for themselves and we look forward to collaborating with both of them on future offerings.”
About ValueSetters: Led by a team of professional investors, digital marketing experts, and technology specialists, ValueSetters is a publicly-traded boutique advisory firm with unique expertise in helping early stage companies raise capital over the internet. The company also provides technology consulting services as well as strategic advice to help companies grow and evolve to meet the challenges of today's marketplace. For more information, visit our website at https://valuesetters.com.
About Phoenix PharmaLabs: Phoenix PharmaLabs (PPL) is a preclinical drug discovery company dedicated to the development of potent, non-addictive treatment for pain and treatments for addiction. For more information, please visit our website at https://phoenixpharmalabs.com
https://finance.yahoo.com/news/valuesetters-a...00062.html
“The ValueSetters team was proud and honored to work with Phoenix PharmaLabs, a company that is working to address the opioid crisis with their non-addictive pain killer,” said Cecilia Lenk, CEO of ValueSetters. “Phoenix PharmaLabs has a powerful mission. More than 2 million Americans are seriously addicted to opioids, and the funds that were raised in their offering will be used to help address this national crisis.”
“ValueSetters played a critical role in the success of our offering,” said Bill Crossman, President & CEO of Phoenix PharmaLabs. “Their unique expertise in the digital marketing of private capital raises drove significant investment dollars. They really rose to the challenge, and we were pleased with their collaborative approach.”
Jackson Stone, Head of Business Development at Netcapital, added, “We referred Phoenix PharmaLabs to ValueSetters because Phoenix sought support from an experienced partner in our industry, and we are happy they chose to work together. The impressive results Phoenix and ValueSetters generated speak for themselves and we look forward to collaborating with both of them on future offerings.”
About ValueSetters: Led by a team of professional investors, digital marketing experts, and technology specialists, ValueSetters is a publicly-traded boutique advisory firm with unique expertise in helping early stage companies raise capital over the internet. The company also provides technology consulting services as well as strategic advice to help companies grow and evolve to meet the challenges of today's marketplace. For more information, visit our website at https://valuesetters.com.
About Phoenix PharmaLabs: Phoenix PharmaLabs (PPL) is a preclinical drug discovery company dedicated to the development of potent, non-addictive treatment for pain and treatments for addiction. For more information, please visit our website at https://phoenixpharmalabs.com
https://finance.yahoo.com/news/valuesetters-a...00062.html
(0)
(0)Scroll down for more posts ▼